Archimed is one of the world’s leading investment platforms in the healthcare sector, covering all stages of development and all segments of the industry: medical devices, diagnostics, life sciences tools, animal and environmental health, consumer health, and pharmaceutical services. The fund targets technology or science-intensive companies whose products help improve the quality and accessibility of healthcare in Europe and North America. It is therefore an exceptional platform for Aurae to gain insights.
For us, Archimed offers a unique vantage point on the entire European and North American healthcare ecosystem, across its many components. We see Archimed as a key partner in refining our perspective on the accessibility and quality of care, identifying the best innovations, and exploring co-investments in companies with strong technological or scientific expertise.
Copyright © 2026 AURæ
